LOGIN  |  REGISTER
Cue Biopharma

Recent Insider Transactions - Actuate Therapeutics (NASDAQ: ACTU)

Follow NASDAQ:ACTU Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ACTU Actuate Therapeutics
SCHMITT DANIEL M / director, officer: President, CEO and Director
04/01/2025
Buy
$6.70
204,285
$1.369M
204,285
NASDAQ ACTU Actuate Therapeutics
SCHMITT DANIEL M / director, officer: President, CEO and Director
04/01/2025
Buy
$6.70
66,503
$446K
66,503
NASDAQ ACTU Actuate Therapeutics
Mazar Andrew Paul / officer: Chief Operating Officer
04/01/2025
Buy
$6.70
110,346
$739K
110,346
NASDAQ ACTU Actuate Therapeutics
Mazar Andrew Paul / officer: Chief Operating Officer
04/01/2025
Buy
$6.70
51,046
$342K
51,046
NASDAQ ACTU Actuate Therapeutics
LYTLE PAUL J / officer: Chief Financial Officer
04/01/2025
Buy
$6.70
49,394
$331K
49,394
NASDAQ ACTU Actuate Therapeutics
LYTLE PAUL J / officer: Chief Financial Officer
04/01/2025
Buy
$6.70
41,899
$281K
41,899

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous